Eliot A Brinton

15PUBLICATIONS
61CO-AUTHORS
Medical devicesInfant and child healthEpidemiological methodsCardiology (incl. cardiovascular diseases)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT.

Chen Gurevitz, Deepak L Bhatt, Robert P Giugliano

|Mar 17, 2025
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia.

Sébastien Bihorel, Robert Dingman, Jeanne Mendell

|Feb 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.

Rahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg

|Jan 22, 2024
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.

Neila Sayah, Deepak L Bhatt, Michael Miller

|Dec 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States.

William S Weintraub, Deepak L Bhatt, Zugui Zhang

|Oct 20, 2023
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia.

Albert Wiegman, Susanne Greber-Platzer, Shazia Ali

Pageof 3